MAI Capital Management’s CASI Pharmaceuticals CASI Stock Holding History

MAI Capital Management’s Portfolio CASI Stock Details CASI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5	Closed	-$5	–	5037
2025 Q4	$5	Hold	5	–	–	﹤0.01%	4335
2025 Q3	$9	Hold	5	–	–	﹤0.01%	3786
2025 Q2	$6	Hold	5	–	–	﹤0.01%	3946
2025 Q1	$11	Hold	5	–	–	﹤0.01%	3418
2024 Q4	$15	Buy	+5	New	+$24	﹤0.01%	3469

Other funds holding CASI

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

MAI Capital Management's CASI Position: Q1 2026 in Review

MAI Capital Management sold out of CASI Pharmaceuticals (CASI) in Q1 2026, closing a stake of 5 shares — an estimated $5 sold.

MAI Capital Management first reported a position in CASI in Q4 2024 and held it in 5 quarters. The position peaked at $15 in Q4 2024. 1 fund tracked by Wall St. Rank holds CASI as of Q1 2026.

MAI Capital Management reported no remaining CASI Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
MAI Capital Management sold 5 CASI Pharmaceuticals shares in Q1 2026, an estimated $5.
MAI Capital Management first reported a position in CASI Pharmaceuticals in Q4 2024 and held it in 5 quarters.
MAI Capital Management's CASI Pharmaceuticals position peaked at $15 in Q4 2024.
1 fund tracked by Wall St. Rank held CASI Pharmaceuticals as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.